Skip to main content
Clinical Trials/ACTRN12615000115538
ACTRN12615000115538
Suspended
Phase 2

The Torpido2 Study: Targeted Oxygenation in the Respiratory care of Premature Infants at Delivery: Effects on developmental Outcome

niversity of Sydney0 sites1,200 target enrollmentFebruary 10, 2015

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Oxidative stress in premature infants
Sponsor
niversity of Sydney
Enrollment
1200
Status
Suspended
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 10, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Birth at 23 weeks to 28 weeks 6 days gestation
  • Signed, written informed consent by parent(s) or legal guardian

Exclusion Criteria

  • Delivery outside study centre
  • Any major cardiopulmonary abnormalities that could affect oxygenation or congenital malformations that could affect neuro\-developmental outcome
  • Anticipated inability to follow\-up at 2 years

Outcomes

Primary Outcomes

Not specified

Similar Trials